The efficacy and safety outcomes of bevacizumab and systemic therapy in metastatic colorectal cancer patients with peritoneal disease in the AGITG MAX clinical trial and in nontrial patients in two cancer centers.
Aflah Roohullah
No relevant relationships to disclose
Katrin Marie Sjoquist
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose
Weng Ng
No relevant relationships to disclose
Wei Chua
No relevant relationships to disclose
Timothy Jay Price
Consultant or Advisory Role - Roche (U)
Niall C. Tebbutt
Consultant or Advisory Role - Roche (U)
Lorraine A. Chantrill
No relevant relationships to disclose